Literature DB >> 32301008

Overview of Basic Immunology and Clinical Application.

Bettzy Stephen1, Joud Hajjar2.   

Abstract

Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and cross-talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.

Entities:  

Keywords:  Adaptive; Biomarkers; Checkpoint inhibitors; Immune cells; Immune checkpoints; Immunology; Immunotherapy; Innate; Resistance; Response; T cells; Translational

Mesh:

Year:  2020        PMID: 32301008     DOI: 10.1007/978-3-030-41008-7_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  The immune system, cancer, and pathogens: It takes three to tango!

Authors:  Joud Hajjar
Journal:  J Immunother Precis Oncol       Date:  2021-05-14

2.  Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages.

Authors:  Zheng Zeng; Yu Liu; Qinglian Wen; Yixian Li; Jing Yu; Qiang Xu; Wenwu Wan; Yu He; Chen Ma; Yan Huang; Helin Yang; Ou Jiang; Fuyu Li
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

3.  High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.

Authors:  Yong-Guang Wei; Cheng-Kun Yang; Zhong-Liu Wei; Xi-Wen Liao; Yong-Fei He; Xin Zhou; Hua-Sheng Huang; Chen-Lu Lan; Chuang-Ye Han; Tao Peng
Journal:  Int J Gen Med       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.